- US FDA approved the IND application for phase I clinical trial in 28 days!
- European Patent Office granted the anti-myopia patent application.
- 2020 Taiwan Ministry of Economic Affairs; “Break Out and Soar High” Award
- The Founder was selected as an elite in translational science by Taiwan government
- The anti-myopia patent was granted in Korea
- The anti-myopia patent was granted in Japan
- The anti-myopia patent was granted in the USA
- The anti-myopia patent was granted in Taiwan, ROC
Develop new drugs and medical equipment to treat eye diseases and to maintain good eyesight.
Create innovative ophthalmic products to protect your eyesight
In the early research stage, the core team received both financial and administrative supports from the Taiwan Ministry of Science and Technology. The team developed the proprietary technology for novel anti-myopia eye drops. With the assistance from Taiwan Startup Institute, the team established Sunhawk Vision Biotech, Inc. in August 2019. The Company facilitates the translation of early R&D results to final ophthalmic products. The anti-myopia eye drop is planned to enter human clinical trials to confirm its safety and effectiveness. It is expected that the novel anti-myopia medication will successfully move to the NDA stage and enter the Asian market as well as global market.
- Dr. Liang
- Dr. Hank Juo
myopia genetic studieslink to recommended research articlesmore+
myopia genetic studies
IMI - Myopia Genetics Report. Tedja MS, Haarman AEG, Meester-Smoor MA, Kaprio J, Mackey DA, Guggenheim JA, Hammond CJ, Verhoeven VJM, Klaver CCW; CREAM Consortium. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M89-M105. doi: 10.1167/iovs.18-25965. Review.
IMicroRNA-328 may influence myopia development by mediating the PAX6 gene.Chen KC, Hsi E, Hu CY, Chou WW, Liang CL, Juo SH. Invest Ophthalmol Vis Sci. 2012 May 31;53(6):2732-9.
Impact of family history of high myopia on level and onset of myopia. Liang CL, Yen E, Su JY, Liu C, Chang TY, Park N, Wu MJ, Lee S, Flynn JT, Juo SH. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3446-52.
studies of myopia controllink to recommended research articlesmore+
studies of myopia control
Review: Myopia control strategies recommendations from the 2018 WHO/IAPB/BHVI Meeting on Myopia. Ang M, Flanagan JL, Wong CW, MÃ¼ller A, Davis A, Keys D, Resnikoff S, Jong M, Wong TY, Sankaridurg P. Br J Ophthalmol. 2020 Feb 26.
Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis. Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, Saw SM, Chen H, Bao F, Zhao Y, Hu L, Li X, Gao R, Lu W, Du Y, Jinag Z, Yu A, Lian H, Jiang Q, Yu Y, Qu J. Ophthalmology. 2016 Apr;123(4):697-708.